Poor commercial real estate. Fewer investors want to touch it after being burned by falling property values in recent years. They have better options anyway. Why settle for 7% annual returns on real ...
WASHINGTON — The U.S. Food and Drug Administration has approved a reformulated version of ranitidine, which was sold widely under the brand name Zantac, allowing the acid-reducing drug to return to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback